Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Emerging Therapies
Emerging Therapies
SGLT-2 Inhibitors Show Durability in Glycemic Control, Weight-Loss Maintenance
Read More
Emerging Therapies
Pazopanib: First Positive Maintenance Trial in Ovarian Cancer
Read More
Emerging Therapies
First-in-Class Angiotensin Receptor Neprilysin Inhibitor Promising in Heart Failure with Preserved Ejection Fraction
Read More
Emerging Therapies
RELAX-AHF: Serelaxin Reduces Dyspnea in Acute Heart Failure
Read More
Emerging Therapies
GLP-1 Agonism Holds Promise for Preventing Macrovascular Disease in Type 2 Diabetes
Read More
Emerging Therapies
CVD Pipeline: Novel Approaches to Modifying Lipids/Lipoproteins
Read More
Emerging Therapies
Empagliflozin Safe and Effective with or without Metformin, Reduces Weight
Read More
Emerging Therapies
Lixisenatide Continues to Show Good Results in GetGoal Program Studies
Read More
Emerging Therapies
New Long-Acting Insulin Degludec Lowers Hypoglycemia Significantly versus Insulin Glargine
Read More
Emerging Therapies
The Ancient Anti-Inflammatory Drug Salsalate Lowers Blood Glucose Levels
Read More
3
4
5
6
7
Page 6 of 7
Results 51 - 60 of 67